Infectious Diseases (except HIV/AIDS)
Showing page 240 of 716 pages of list content
-
Infrared spectroscopy enables rapid, robust, portable COVID-19 saliva screening based on pathophysiological response to SARS-CoV-2
This article's authors -
Serum anti-Spike antibody titers before and after heterologous booster with mRNA-1273 SARS-CoV-2 vaccine following two doses of inactivated whole-virus CoronaVac vaccine
This article's authors -
Evaluation of the Implementation of the 4C Mortality Score in United Kingdom hospitals during the second pandemic wave
This article's authors -
Neutralising antibody activity against SARS-CoV-2 variants, including Omicron, in an elderly cohort vaccinated with BNT162b2
This article's authors -
Three doses of the BNT162b2 vaccine confer neutralising antibody capacity against the SARS-CoV-2 B.1.1.529 (Omicron) variant of concern
This article's authors -
Healthcare workers’ COVID-19 Omicron variant uncertainty-related stress, resilience, and coping strategies during the first week of World Health Organization alert
This article's authors -
Saliva swabs are the preferred sample for Omicron detection
This article's authors -
Relative Importance of Various Inflammatory Markers and Their Critical Thresholds for COVID-19 Mortality
This article's authors -
Effectiveness of BNT162b2 and mRNA-1273 Second Doses and Boosters for SARS-CoV-2 infection and SARS-CoV-2 Related Hospitalizations: A Statewide Report from the Minnesota Electronic Health Record Consortium
This article's authors -
SARS-CoV-2 vaccine Alpha and Delta variant breakthrough infections are rare and mild, but happen relative early after vaccination
This article's authors